Rhonda S Woerndle

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, T. Girard, 2009, Bioorganic & medicinal chemistry letters.

Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).

D. Rohrer, C. Carron, C. Wegner, 2010, ACS medicinal chemistry letters.

Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Journal of medicinal chemistry.

Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, P. Harris, 2010, Bioorganic & medicinal chemistry letters.

Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.

M. Heron, J. Collins, D. J. Garland, 2010, Journal of medicinal chemistry.

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.

S. Rapp, M. D. Ennis, T. Girard, 2009, Bioorganic & medicinal chemistry letters.

Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.

M. Heron, J. Collins, D. J. Garland, 2010, Journal of medicinal chemistry.